These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
812 related items for PubMed ID: 7521168
21. A functional polymorphism in the MAOA gene promoter (MAOA-LPR) predicts central dopamine function and body mass index. Ducci F, Newman TK, Funt S, Brown GL, Virkkunen M, Goldman D. Mol Psychiatry; 2006 Sep; 11(9):858-66. PubMed ID: 16770335 [Abstract] [Full Text] [Related]
22. Monoamine metabolites in human cerebrospinal fluid: indicators of neuronal activity? Scheinin M. Med Biol; 1985 Sep; 63(1):1-17. PubMed ID: 2582215 [Abstract] [Full Text] [Related]
23. [Clinical course and CSF monoamine metabolism in neuroleptic malignant syndrome--a study of nine typical cases and five mild cases]. Nishijima K, Ishiguro T. Seishin Shinkeigaku Zasshi; 1989 Sep; 91(6):429-56. PubMed ID: 2479043 [Abstract] [Full Text] [Related]
24. [The changes of monoamine metabolites in CSF of patients with cerebral stroke]. Tang HZ. Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1991 Jun; 24(3):130-2, 186. PubMed ID: 1716195 [Abstract] [Full Text] [Related]
25. Biogenic amine metabolites and thiamine in cerebrospinal fluid in heredo-degenerative ataxias. Botez MI, Young SN. Can J Neurol Sci; 2001 May; 28(2):134-40. PubMed ID: 11383938 [Abstract] [Full Text] [Related]
26. No major influence of regular tobacco smoking on cerebrospinal fluid monoamine metabolite concentrations in patients with psychotic disorder and healthy individuals. Hjärpe J, Söderman E, Andreou D, Sedvall GC, Agartz I, Jönsson EG. Psychiatry Res; 2018 May; 263():30-34. PubMed ID: 29482043 [Abstract] [Full Text] [Related]
27. [beta-Endorphin and monoamine metabolite concentrations in patients with intractable pain--changes before and after deep brain or spinal dorsal column stimulation]. Namba S, Fujiwara N, Namba Y, Nishimoto A. No To Shinkei; 1985 Aug; 37(8):775-83. PubMed ID: 2416330 [Abstract] [Full Text] [Related]
28. Postmortem changes in the levels of monoamine metabolites in human cerebrospinal fluid. Endo T, Hara S, Kuriiwa F, Kano S. Forensic Sci Int; 1990 Jan; 44(1):61-8. PubMed ID: 1689267 [Abstract] [Full Text] [Related]
29. Concentrations of monoamine metabolites and chlorpromazine in cerebrospinal fluid for prediction of therapeutic response in psychotic patients treated with neuroleptic drugs. Sedvall G. Prog Biochem Pharmacol; 1980 Jan; 16():133-40. PubMed ID: 6160594 [Abstract] [Full Text] [Related]
30. CSF monoamine metabolite levels in Alzheimer's and Parkinson's disease. Gibson CJ, Logue M, Growdon JH. Arch Neurol; 1985 May; 42(5):489-92. PubMed ID: 2581531 [Abstract] [Full Text] [Related]
31. Influence of parenting style on the offspring's behaviour and CSF monoamine metabolite levels in crossfostered and noncrossfostered female rhesus macaques. Maestripieri D, McCormack K, Lindell SG, Higley JD, Sanchez MM. Behav Brain Res; 2006 Nov 25; 175(1):90-5. PubMed ID: 16971003 [Abstract] [Full Text] [Related]
32. Visual and auditory evoked potentials in early onset Parkinson's disease and their relationship to cerebrospinal fluid monoamine metabolites. Muthane UB, Satishchandra P, Subhash MN. Mov Disord; 1993 Jul 25; 8(3):344-8. PubMed ID: 7688076 [Abstract] [Full Text] [Related]
33. Monoamine metabolites in successive samples of spinal fluid. A comparison between healthy volunteers and patients with multiple sclerosis. Andersen O, Johansson BB, Svennerholm L. Acta Neurol Scand; 1981 Apr 25; 63(4):247-54. PubMed ID: 6163303 [Abstract] [Full Text] [Related]
34. Increased concentrations of the monoamine metabolites homovanillic acid and 5-hydroxyindoleacetic acid in lumbar and central CSF and of 3-methoxy-4-hydroxyphenylglycol in lumbar CSF after subarachnoid haemorrhage. von Holst H, Lindquist C, Sedvall G. Acta Neurochir (Wien); 1985 Apr 25; 77(3-4):146-51. PubMed ID: 2416192 [Abstract] [Full Text] [Related]
35. Cerebrospinal fluid monoamine metabolite concentrations in depressive disorder: A meta-analysis of historic evidence. Ogawa S, Tsuchimine S, Kunugi H. J Psychiatr Res; 2018 Oct 25; 105():137-146. PubMed ID: 30219563 [Abstract] [Full Text] [Related]
36. Dystrobrevin-binding protein 1 gene (DTNBP1) variants associated with cerebrospinal fluid homovanillic acid and 5-hydroxyindoleacetic acid concentrations in healthy volunteers. Andreou D, Saetre P, Kähler AK, Werge T, Andreassen OA, Agartz I, Sedvall GC, Hall H, Terenius L, Jönsson EG. Eur Neuropsychopharmacol; 2011 Sep 25; 21(9):700-4. PubMed ID: 21295953 [Abstract] [Full Text] [Related]
37. Relationship of CSF neurotransmitter metabolite levels to disease severity and disability in multiple sclerosis. Markianos M, Koutsis G, Evangelopoulos ME, Mandellos D, Karahalios G, Sfagos C. J Neurochem; 2009 Jan 25; 108(1):158-64. PubMed ID: 19014375 [Abstract] [Full Text] [Related]
38. Monoamine metabolites in the CSF of epileptic patients. Laxer KD, Sourkes TL, Fang TY, Young SN, Gauthier SG, Missala K. Neurology; 1979 Aug 25; 29(8):1157-61. PubMed ID: 37460 [Abstract] [Full Text] [Related]
39. Characterization of cerebrospinal fluid monoamine metabolites in peripubertal chimpanzees (Pan troglodytes). Fontenot MB, Musso MW, Watson SL, Anderson GM. J Med Primatol; 2010 Feb 25; 39(1):24-31. PubMed ID: 19843204 [Abstract] [Full Text] [Related]
40. Tardive dyskinesia and neurotransmitters: effects of sodium valproate, cyproheptadine, oxypertine, hydroxyzine pamoate and Ca-hopantenate on monoamine metabolites, cyclic nucleotides and gamma-aminobutyric acid in human cerebrospinal fluid. Ogawa T, Nagao T, Kashiwabara K, Fujiwara Y, Harada T, Otsuki S. Clin Ther; 1984 Feb 25; 7 Spec No():1-17. PubMed ID: 6085032 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]